| Dwight J Hertz, MD | |
|
222 N 7th St, Bismarck, ND 58501-4436 | |
| (701) 323-6000 | |
| (701) 323-5709 |
| Full Name | Dwight J Hertz |
|---|---|
| Gender | Male |
| Speciality | Pathology - Clinical Pathology/laboratory Medicine |
| Location | 222 N 7th St, Bismarck, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164535043 | NPI | - | NPPES |
| 16184 | Medicaid | ND |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0105X | Pathology - Clinical Pathology/laboratory Medicine | 5462 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dwight J Hertz, MD Po Box 5501, Bismarck, ND 58506-5501 Ph: (701) 323-6000 | Dwight J Hertz, MD 222 N 7th St, Bismarck, ND 58501-4436 Ph: (701) 323-6000 |
News Archive
"At least four million Americans under age 65 are exposed to high doses of radiation each year from medical imaging tests, according to a new study in The New England Journal of Medicine," The New York Times reports. And about ten percent of those patients "receive very high doses, more than the maximum annual exposure allowed for nuclear power plant employees or anyone else who works with radioactive material." The study was based on a survey of nearly one million patients insured by UnitedHealthcare.
Telormedix, a clinical stage biopharmaceutical company focused on targeted immunity in the treatment of cancer and other diseases, today announced the start of a Phase I/II clinical study of TMX-101 for the treatment of Non-Muscle Invasive Bladder Cancer. TMX-101 is an immunotherapeutic compound and Telormedix has already recruited the first patients for this clinical study.
Two experimental DNA vaccines to prevent Ebola virus and the closely related Marburg virus [1] are safe, and generated a similar immune response in healthy Ugandan adults as reported in healthy US adults earlier this year.
Sagent Pharmaceuticals, announced that it has commenced an initial public offering of 5,000,000 shares of common stock.
› Verified 7 days ago
Jared Lee Schmidt, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3502 Franklin Ave, Bismarck, ND 58503 Phone: 701-222-2480 Fax: 701-222-4537 | |
Laurie Linz, Pathology Medicare: Not Enrolled in Medicare Practice Location: 3502 Franklin Ave, Bismarck, ND 58503 Phone: 701-222-2480 Fax: 701-222-4537 | |
Stephen M. Berns, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 222 N 7th St, Bismarck, ND 58501 Phone: 701-323-5422 Fax: 701-323-8645 | |
Yat-sun Leung, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 222 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 Fax: 701-323-5709 | |
Dr. Sydney Lyle Rooney, MD Pathology Medicare: Medicare Enrolled Practice Location: 222 N 7th St, Bismarck, ND 58501 Phone: 701-323-5422 Fax: 701-323-8645 | |
John Hipp, Pathology Medicare: Not Enrolled in Medicare Practice Location: 3502 Franklin Ave, Bismarck, ND 58503 Phone: 701-222-2480 Fax: 701-222-4537 |